StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.29−0.13 (-9.15%)

Close on Nov 20, 2026Market cap $5.02MP/E –Yield –

Quantum Biopharma free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2024 it was -$6.88M. The highest annual figure on record is -$6.88M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2024Dec 31, 2024-$6.88M–
FY2023Dec 31, 2023-$10.83M–
FY2022Dec 31, 2022-$28.45M–
FY2021Dec 31, 2021-$20.75M–
FY2020Dec 31, 2020-$19.13M–

More Quantum Biopharma figures

See a number that looks wrong?